Abivax SA Sponsored ADR (ABVX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Abivax has launched an At-The-Market (ATM) program on Nasdaq, allowing the company to raise up to $150 million by issuing American Depositary Shares (ADS) over the next three years. This strategic move is aimed at supporting its clinical programs and general corporate purposes, providing flexibility in its financing strategy. Piper Sandler & Co. will act as the sales agent, facilitating the sale of ADSs to eligible investors.
For further insights into ABVX stock, check out TipRanks’ Stock Analysis page.